Ipca Laboratories Ltd

NSE: IPCALAB · BSE: 524494 · Pharmaceuticals & Biotechnology · 20 announcements

Share price: ₹1,945.50
Market cap: ₹49,358 Cr
Revenue (annual): ₹9,646 Cr
Net profit (annual): ₹1,141 Cr
P/E (TTM): 37.7×Sector 47.4×
Promoter holding: 44.72%+0.00% QoQ
FII holding: 10.72%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 3 Other Announcement 2 Merger & Restructuring 2 Earnings Call 2 Dividend 2 Board Meeting Date 2 Annual General Meeting 2 Partnership 1 Management Change 1 Credit Rating 1 Business Update 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

13 Aug 2026 13:34 IST BSE

Financial ResultsAlfa Alert

Ipca Laboratories Q1 FY27 Results: Net Profit ₹424.3 Cr, Up 82.2% YoY

Ipca Laboratories Ltd reported revenue from operations of ₹2,788 Cr (+20.8% YoY) and net profit of ₹424.3 Cr (+82.2% YoY) for Q1 FY27.

Key figure: Net profit ₹424.3 Cr · +82.2% YoY

Open full results → Read the filing ↗

29 May 2026 13:49 IST BSE

Financial Results

Ipca Laboratories Q4 FY26 Results: Net Profit ₹306.7 Cr, Up 379.2% YoY

Ipca Laboratories Ltd reported revenue from operations of ₹2,388 Cr (+6.3% YoY) and net profit of ₹306.7 Cr (+379.2% YoY) for Q4 FY26.

Key figure: Net profit ₹306.7 Cr · +379.2% YoY

Open full results → Read the filing ↗

29 May 2026 13:49 IST BSE

Financial Results

Ipca Laboratories Financial Results

Ipca Laboratories reported FY26 consolidated net profit of ₹1,141.12 Crore. The board recommended a ₹6 per share dividend, signaling strong financial performance and shareholder returns.

Value: ₹15.22 Cr

Read the filing ↗